Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Adoptive Transfer of T Cell Help Breaks Tolerance in Endogenous, Tumor-Specific CD8 + T Cells Responding to a Growing Tumor.

Jie Wang, MD, Maryam Aalamian, MD, Sanju Jalla, PhD, Leo Luznik, MD, Ephraim J. Fuchs, MD

Blood (2004) 104 (11): 3056.

https://doi.org/10.1182/blood.V104.11.3056.3056

Published: 2004

Journal Articles

Cyclophosphamide Plus Allogeneic CD4 + T Cell Infusion Induces Anti-Lymphoma Immunity Despite Lack of Graft-Versus-Host Disease (GVHD) or Sustained Engraftment.

Sanju Jalla, PhD, Jie Wang, MD, Leo Luznik, MD, Ephraim J. Fuchs, MD

Blood (2004) 104 (11): 3063.

https://doi.org/10.1182/blood.V104.11.3063.3063

Published: 2004

Journal Articles

Augmentation of Therapeutic Tumor Vaccine Efficacy by Genetic Engineering of CD4 + T Cell Help for Tumor Vaccine-Reactive CD8 + T Cells.

Sanju Jalla, PhD, Erin McCadden, Jie Wang, MD, Ephraim J. Fuchs, MD, Katharine A. Whartenby, PhD

Blood (2004) 104 (11): 3175.

https://doi.org/10.1182/blood.V104.11.3175.3175

Published: 2004

Journal Articles

Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimeras

Leo Luznik, Jill E. Slansky, Sanju Jalla, Ivan Borrello, Hyam I. Levitsky, Drew M. Pardoll, Ephraim J. Fuchs

Blood (2003) 101 (4): 1645–1652.

https://doi.org/10.1182/blood-2002-07-2233

Published: 2003

Journal Articles

Durable engraftment of major histocompatibility complex–incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide

Leo Luznik, Sanju Jalla, Laura W. Engstrom, Robert Iannone, Ephraim J. Fuchs

Blood (2001) 98 (12): 3456–3464.

https://doi.org/10.1182/blood.V98.12.3456

Published: 2001

NARROW

Adoptive Transfer of T Cell Help Breaks Tolerance in Endogenous, Tumor-Specific CD8 + T Cells Responding to a Growing Tumor.

Cyclophosphamide Plus Allogeneic CD4 + T Cell Infusion Induces Anti-Lymphoma Immunity Despite Lack of Graft-Versus-Host Disease (GVHD) or Sustained Engraftment.

Augmentation of Therapeutic Tumor Vaccine Efficacy by Genetic Engineering of CD4 + T Cell Help for Tumor Vaccine-Reactive CD8 + T Cells.

Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimeras

Durable engraftment of major histocompatibility complex–incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide

Email alerts

ASH Publications

American Society of Hematology

Adoptive Transfer of T Cell Help Breaks Tolerance in Endogenous, Tumor-Specific CD8 + T Cells Responding to a Growing Tumor.

Cyclophosphamide Plus Allogeneic CD4 + T Cell Infusion Induces Anti-Lymphoma Immunity Despite Lack of Graft-Versus-Host Disease (GVHD) or Sustained Engraftment.

Augmentation of Therapeutic Tumor Vaccine Efficacy by Genetic Engineering of CD4 + T Cell Help for Tumor Vaccine-Reactive CD8 + T Cells.

Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimeras

Durable engraftment of major histocompatibility complex–incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only